首页> 外文OA文献 >Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients

【2h】

Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients

机译：Systems评估化疗和EGFR TKIS与化疗或EGFR TKIs的嵌入组合或EGFR TKIs在先进的NSCLC患者中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Han Yan; Qin Li; Wei Wang; Hongchao Zhen; Bangwei Cao;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients [J] . Han Yan, Qin Li, Wei Wang, Scientific reports. . 2015,第1期

机译：晚期非小细胞肺癌患者化疗与EGFR TKI的插组合联合与单独化疗或EGFR TKI的系统评估
2. Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients [J] . Han Yan, Qin Li, Wei Wang, Scientific reports. . 2015,第1期

机译：晚期非小细胞肺癌患者化疗与EGFR TKI的插组合联合与单独化疗或EGFR TKI的系统评估
3. Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation [J] . Miaomiao Wen, Jinghua Xia, Ying Sun, Biologics: Targets and Therapy . 2018,第2期

机译：EGFR-TKIs联合化疗与单纯EGFR-TKIs联合治疗晚期EGFR突变的非小细胞肺癌患者
4. Intratumor Heterogeneity of EGFR Activating Mutations in Advanced NSCLC Patients at Single-Cell Level [C] . Liu Yuefen International Conference on Biomedical Engineering, Machinery and Earth Science . 2018

机译：单细胞水平晚期NSCLC患者EGFR激活突变的细胞内异质性
5. The Effectiveness of EGFR-TKIs in Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis. [D] . Li, Xiao. 2016

机译：EGFR-TKIs在非小细胞肺癌治疗中的有效性：一项荟萃分析。
6. Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients [O] . Han Yan, Qin Li, Wei Wang, -1

机译：晚期NSCLC患者化疗与EGFR TKI的插组合联合与单独化疗或EGFR TKI的系统评估
7. First-generation EGFR-TKI plus chemotherapy versus EGFR-TKI alone as first-line treatment in advanced NSCLC with EGFR activating mutation: a systematic review and meta-analysis of randomized controlled trials [O] . Qiang Wu, Wuxia Luo, Wen Li, 2020

机译：第一代EGFR-TKI加上化疗与EGFR-TKI单独作为高级NSCLC的一线治疗，具有EGFR激活突变：随机对照试验的系统评价和荟萃分析

Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients

著录项

引文网络

相似文献

相关主题

期刊订阅